Status:

COMPLETED

Exhaled Levels of Nitric Oxide

Lead Sponsor:

VA Office of Research and Development

Conditions:

Tetraplegia

Asthma

Eligibility:

All Genders

18-65 years

Phase:

PHASE2

PHASE3

Brief Summary

Previously it was observed that individuals with tetraplegia have reduced baseline airway caliber and exhibit non-specific airway hyperresponsiveness (AHR). In persons with tetraplegia we have suggest...

Detailed Description

The study requires a maximum of five study visits in the following order: 1. nebulized normal saline, 2. nebulized 1mg/kg of L-NAME (see below), 3. intravenous normal saline, 4. intravenous 1 mg/kg L-...

Eligibility Criteria

Inclusion

  • Written informed consent.
  • Age between 18 and 65 years.
  • Able-bodied individuals, persons with mild asthma or individuals with tetraplegia for at least one year of duration.
  • Able to perform acceptable pulmonary function tests and follow procedures.

Exclusion

  • coronary artery disease;
  • active cigarette smokers or previous smokers who stopped \<5 years ago;
  • MI or stroke within 3 months;
  • moderate to severe reduction in lung function defined as FEV1 \< 70 % predicted (except in individuals with tetraplegia);
  • hypertension;
  • medications known to affect the cardiovascular system;
  • pregnancy
  • current use of cholinesterase medication; and
  • lack of mental capacity to give informed consent Group specific exclusion criteria for
  • Asthmatic subjects:
  • Moderate to severe disease as per spirometric indices;
  • testing within 48 hours of last administration of long acting inhaled bronchodilator;
  • testing within 7 days of last administration of glucocorticoids;
  • testing within \> 24 hours since last administration of leukotriene modifiers; and
  • testing within 8 hours of last administration of a short acting bronchodilator medication

Key Trial Info

Start Date :

December 1 2006

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

August 1 2010

Estimated Enrollment :

23 Patients enrolled

Trial Details

Trial ID

NCT00753948

Start Date

December 1 2006

End Date

August 1 2010

Last Update

February 28 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

VA Medical Center, Bronx

The Bronx, New York, United States, 10468

Exhaled Levels of Nitric Oxide | DecenTrialz